דטסקאן

Valsts: Izraēla

Valoda: ivrits

Klimata pārmaiņas: Ministry of Health

Aktīvā sastāvdaļa:

IOFLUPANE

Pieejams no:

ELDAN ELECTRONIC INSTRUMENTS CO LTD

ATĶ kods:

V09AB03

Zāļu forma:

תמיסה להזרקה

Kompozīcija:

IOFLUPANE 74 MBQ/ML

Ievadīšanas:

תוך-ורידי

Receptes veids:

מרשם נדרש

Ražojis:

GE HEALTHCARE B.V., THE NETHERLAND

Ārstniecības grupa:

OTHER DOPAMINERGIC AGENTS

Ārstniecības joma:

IODINE IOFLUPANE (123I)

Ārstēšanas norādes:

Datscan is indicated for detecting loss of functional dopaminergic neuron terminals in the striatum: - of patients with clinically uncertain Parkinsonian Syndromes in order to help differentiate Essential Tremor from Parkinsonian Syndromes related to idiopathic Parkinson's Disease Multiple System Atrophy and Progressive Supranuclear Palsy. - Datscan is unable to discriminate between Parkinson's Disease Multiple System Atrophy and Progressive Supranuclear Palsy. - To help differentiate probable dementia with Lewy bodies from Alzheimer's disease. Datscan is unable to discriminate between dementia with Lewy bodies and Parkinson's disease dementia

Autorizācija datums:

2014-11-30